Neurological complications during veno-venous extracorporeal membrane oxygenation: Does the configuration matter? A retrospective analysis of the ELSO …

R Lorusso, M Belliato, M Mazzeffi, M Di Mauro… - Critical Care, 2021 - Springer
Background Single-(SL) and double-lumen (DL) catheters are used in clinical practice for
veno-venous extracorporeal membrane oxygenation (VV ECMO) therapy. However …

Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis

G De Pascale, F De Maio, S Carelli, G De Angelis… - Critical Care, 2021 - Springer
Background Hospitalized patients with COVID-19 admitted to the intensive care unit (ICU)
and requiring mechanical ventilation are at risk of ventilator-associated bacterial infections …

Factors associated with outcomes of patients on extracorporeal membrane oxygenation support: a 5-year cohort study

C Aubron, AC Cheng, D Pilcher, T Leong, G Magrin… - Critical Care, 2013 - Springer
Introduction Mortality of patients on extracorporeal membrane oxygenation (ECMO) remains
high. The objectives of this study were to assess the factors associated with outcome of …

Liver function predicts survival in patients undergoing extracorporeal membrane oxygenation following cardiovascular surgery

C Roth, L Schrutka, C Binder, L Kriechbaumer, G Heinz… - Critical Care, 2016 - Springer
Background Extracorporeal membrane oxygenation (ECMO) represents a valuable and
rapidly evolving therapeutic option in patients with severe heart or lung failure following …

Extracorporeal membrane oxygenation in patients with COVID-19: an international multicenter cohort study

SJ Raasveld, TSR Delnoij, LM Broman… - Journal of intensive …, 2021 - journals.sagepub.com
Background: To report and compare the characteristics and outcomes of COVID-19 patients
on extracorporeal membrane oxygenation (ECMO) to non-COVID-19 acute respiratory …

Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China

Z Zeng, H Yu, H Chen, W Qi, L Chen, G Chen, W Yan… - Critical Care, 2020 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19) is a newly emerging infectious
disease and rapidly escalating epidemic caused by the severe acute respiratory syndrome …

Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in …

A Rodríguez, M Ruiz-Botella, I Martín-Loeches… - Critical Care, 2021 - Springer
Background The identification of factors associated with Intensive Care Unit (ICU) mortality
and derived clinical phenotypes in COVID-19 patients could help for a more tailored …

HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients

A Meyer, N Buetti, N Houhou-Fidouh, J Patrier… - Critical Care, 2021 - Springer
Background Data in the literature about HSV reactivation in COVID-19 patients are scarce,
and the association between HSV-1 reactivation and mortality remains to be determined …

Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation

K Shekar, JA Roberts, CI Mcdonald, S Fisquet… - Critical care, 2012 - Springer
Introduction Extracorporeal membrane oxygenation (ECMO) is a supportive therapy, with its
success dependent on effective drug therapy that reverses the pathology and/or normalizes …

Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID …

EJ Kooistra, M van Berkel, NF van Kempen… - Critical Care, 2021 - Springer
Abstract Background Procalcitonin (PCT) and C-reactive protein (CRP) were previously
shown to have value for the detection of secondary infections in critically ill COVID-19 …